首页|期刊导航|中华医学杂志(英文版)|Amyloid and tau positive mild cognitive impairment:clinical and biomarker characteristics of dementia progression
中华医学杂志(英文版)2021,Vol.134Issue(14):1709-1719,11.DOI:10.1097/CM9.0000000000001496
Amyloid and tau positive mild cognitive impairment:clinical and biomarker characteristics of dementia progression
Amyloid and tau positive mild cognitive impairment:clinical and biomarker characteristics of dementia progression
摘要
关键词
Alzheimer disease/Mild cognitive impairment/Amyloid and tau positive mild cognitive impairment/DementiaKey words
Alzheimer disease/Mild cognitive impairment/Amyloid and tau positive mild cognitive impairment/Dementia引用本文复制引用
Hong-Chun Wei,Bing Li,Kok Pin Ng,Qing-Xi Fu,Sheng-Jie Dong,Mao-Wen Ba,Min Kong..Amyloid and tau positive mild cognitive impairment:clinical and biomarker characteristics of dementia progression[J].中华医学杂志(英文版),2021,134(14):1709-1719,11.基金项目
The study was supported by grants from the Shandong Provincial key research and development project(No.2018GSF118235)and the Shandong Provincial Natural Science Foundation(No.ZR2016HL16). (No.2018GSF118235)